(-)-Epicatechin

DRUG4 trials

Sponsors

Craig McDonald, MD, University of California, San Francisco, University Ghent

Conditions

Becker Muscular DystrophyDiet ModificationPulmonary Arterial Hypertension

Phase 1

Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)

CompletedNCT01856868

Craig McDonald, MDBecker Muscular Dystrophy

Start: 2013-05-31End: 2018-09-30Updated: 2021-12-22

(-)-Epicatechin and Pulmonary Arterial Hypertension

WithdrawnNCT01880866

University of California, San FranciscoPulmonary Arterial Hypertension

Start: 2013-07-31End: 2014-01-31Updated: 2014-09-10

Phase 2

(-)- Epicatechin Becker Muscular Dystrophy

CompletedNCT03236662

Craig McDonald, MDBecker Muscular Dystrophy

Start: 2016-11-30End: 2017-12-31Updated: 2021-11-24

Unknown Phase

The Influence of the Microbiome on the Pharmacokinetics of Flavan-3-ols

CompletedNCT05113498

University GhentDiet Modification

Start: 2021-11-01End: 2022-04-26Updated: 2022-04-27